Literature DB >> 28579304

Modelled seasonal influenza mortality shows marked differences in risk by age, sex, ethnicity and socioeconomic position in New Zealand.

Trang Q T Khieu1, Nevil Pierse2, Lucy Frances Telfar-Barnard2, Jane Zhang2, Q Sue Huang3, Michael G Baker2.   

Abstract

OBJECTIVES: Influenza is responsible for a large number of deaths which can only be estimated using modelling methods. Such methods have rarely been applied to describe the major socio-demographic characteristics of this disease burden.
METHODS: We used quasi Poisson regression models with weekly counts of deaths and isolates of influenza A, B and respiratory syncytial virus for the period 1994 to 2008.
RESULTS: The estimated average mortality rate was 13.5 per 100,000 people which was 1.8% of all deaths in New Zealand. Influenza mortality differed markedly by age, sex, ethnicity and socioeconomic position. Relatively vulnerable groups were males aged 65-79 years (Rate ratio (RR) = 1.9, 95% CI: 1.9, 1.9 compared with females), Māori (RR = 3.6, 95% CI: 3.6, 3.7 compared with European/Others aged 65-79 years), Pacific (RR = 2.4, 95% CI: 2.4, 2.4 compared with European/Others aged 65-79 years) and those living in the most deprived areas (RR = 1.8, 95% CI: 1.3, 2.4) for New Zealand Deprivation (NZDep) 9&10 (the most deprived) compared with NZDep 1&2 (the least deprived).
CONCLUSIONS: These results support targeting influenza vaccination and other interventions to the most vulnerable groups, in particular Māori and Pacific people and men aged 65-79 years and those living in the most deprived areas.
Copyright © 2017 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Influenza; Mortality; Regression model; Virus

Mesh:

Year:  2017        PMID: 28579304     DOI: 10.1016/j.jinf.2017.05.017

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  5 in total

1.  The impact of ethnicity on clinical outcomes in COVID-19: A systematic review.

Authors:  Daniel Pan; Shirley Sze; Jatinder S Minhas; Mansoor N Bangash; Nilesh Pareek; Pip Divall; Caroline Ml Williams; Marco R Oggioni; Iain B Squire; Laura B Nellums; Wasim Hanif; Kamlesh Khunti; Manish Pareek
Journal:  EClinicalMedicine       Date:  2020-06-03

2.  Local deprivation status and seasonal influenza vaccination coverage in adults ≥ 65 years residing in the Foggia municipality, Italy, 2009-2016.

Authors:  F Fortunato; G Iannelli; A Cozza; M Del Prete; F V Pollidoro; S Cocciardi; M DI Trani; D Martinelli; R Prato
Journal:  J Prev Med Hyg       Date:  2019-02-28

3.  Prediction of Influenza Complications: Development and Validation of a Machine Learning Prediction Model to Improve and Expand the Identification of Vaccine-Hesitant Patients at Risk of Severe Influenza Complications.

Authors:  Donna M Wolk; Alon Lanyado; Ann Marie Tice; Maheen Shermohammed; Yaron Kinar; Amir Goren; Christopher F Chabris; Michelle N Meyer; Avi Shoshan; Vida Abedi
Journal:  J Clin Med       Date:  2022-07-26       Impact factor: 4.964

4.  Excess pneumonia and influenza mortality attributable to seasonal influenza in subtropical Shanghai, China.

Authors:  Xinchun Yu; Chunfang Wang; Tao Chen; Wenyi Zhang; Huiting Yu; Yuelong Shu; Wenbiao Hu; Xiling Wang
Journal:  BMC Infect Dis       Date:  2017-12-07       Impact factor: 3.090

5.  COVID-19: we must not forget about Indigenous health and equity.

Authors:  Melissa McLeod; Jason Gurney; Ricci Harris; Donna Cormack; Paula King
Journal:  Aust N Z J Public Health       Date:  2020-07-06       Impact factor: 3.755

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.